A universal outcome measure for headache treatments, care-delivery systems and economic analysis

Economic Evaluation of Treatments for Migraine: An Assessment of the Generalizability Following a Systematic Review

(2020) Matteo Ruggeri et al.   PHARMACOECONOMICS

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

(2020) Theo Vos et al.   LANCET

Aids to management of headache disorders in primary care (2nd edition)

(2019) T. J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

(2018)   CEPHALALGIA

The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility

(2018) T. J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Spencer L James et al.   LANCET

Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2018) Lars Jacob Stovner et al.   LANCET NEUROLOGY

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2017) Theo Vos et al.   LANCET

Disability and Disability-Adjusted Life Years: Not the Same

(2017) Scott D. Grosse et al.   PUBLIC HEALTH REPORTS

Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries

(2015) Mattias Linde et al.   JOURNAL OF HEADACHE AND PAIN

Disability weights for the Global Burden of Disease 2013 study

(2015) Joshua A Salomon et al.   Lancet Global Health

What efficacy measures are clinically relevant and should be used in Cochrane Reviews of acute migraine trials? A viewpoint

(2014) Peer Tfelt-Hansen   CEPHALALGIA

What efficacy measures are clinically relevant and should be used in Cochrane reviews of acute migraine trials? An alternative viewpoint

(2014) TJ Steiner   CEPHALALGIA

The methodology of population surveys of headache prevalence, burden and cost: Principles and recommendations from the Global Campaign against Headache

(2014) Lars Jacob Stovner et al.   JOURNAL OF HEADACHE AND PAIN

Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire

(2014) Timothy J Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Productivity impact of headache on a heavy-manufacturing workforce in Turkey

(2013) Macit H Selekler et al.   JOURNAL OF HEADACHE AND PAIN

Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators

(2012) et al.   CEPHALALGIA

Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the ‘Act when Mild’ Study

(2012) John Slof   Applied Health Economics and Health Policy

The cost of headache disorders in Europe: the Eurolight project

(2011) M. Linde et al.   EUROPEAN JOURNAL OF NEUROLOGY

Guidelines for Controlled Trials of Drugs in Tension-Type Headache: Second Edition

(2009) L Bendtsen et al.   CEPHALALGIA

EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force

(2009) S. Evers et al.   EUROPEAN JOURNAL OF NEUROLOGY

Cost-Effectiveness of Acupuncture Treatment in Patients With Headache

(2008) CM Witt et al.   CEPHALALGIA